Home > Income Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹1,656 Cr₹1,245 Cr₹777 Cr₹1,252 Cr₹1,025 Cr

What is the latest Consolidated Net Profit of TORRENT PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of TORRENT PHARMACEUTICALS is ₹1,656 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹1,656 Cr
Mar2024₹1,245 Cr
Mar2023₹777 Cr
Mar2022₹1,252 Cr
Mar2021₹1,025 Cr

How is Consolidated Net Profit of TORRENT PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹1,656 Cr
33.02
Mar2024 ₹1,245 Cr
60.22
Mar2023 ₹777 Cr
-37.92
Mar2022 ₹1,252 Cr
22.17
Mar2021 ₹1,025 Cr -

Compare Consolidated Net Profit of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹128,602.2 Cr 0.5% 2.2% 11.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,708.0 Cr -2.9% -1.8% -2.5% Stock Analytics
DIVIS LABORATORIES ₹171,975.0 Cr 2.1% 0.2% 9.1% Stock Analytics
CIPLA ₹122,539.0 Cr 0.7% -0.8% 3.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,741.0 Cr -0.1% 2.5% 2.5% Stock Analytics
MANKIND PHARMA ₹89,743.8 Cr 1.5% -2.8% -19.5% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

0.5%

2.2%

11.2%

SENSEX

-0.4%

-0.3%

3.9%


You may also like the below Video Courses